Condition: Idiopathic Nephrotic Syndrome (INS) · Sponsor: Assistance Publique - Hôpitaux de Paris
Renal biopsy (RB) is the reference diagnostic procedure for Idiopathic Nephrotic Syndrome (INS). It is an invasive procedure, particularly risky during the acute phase of nephrotic syndrome when anticoagulation therapy is required. By identifying serum antibodies that allow for the non-invasive diagnosis of the main differential diagnoses of INS, (Membranous Nephropathy), the development of a non-invasive diagnostic tool for INS could help reduce the morbidity associated with the invasive renal biopsy procedure, minimizing the risk of incorrect diagnosis. We developed a diagnostic score, the SNIT, from routine clinical and biological variables to allow INS diagnoses in patients for whom detection of blood antibodies of Membranous Nephropathy were negative. The main goal of this study is to validate this diagnosis score in a prospective study, to allow INS diagnosis without renal biopsy.
This description comes directly from the study's public registry record.
Alexandre LAHENS, Dr · +33 1 56 01 70 43 · alexandre.lahens@aphp.fr
Jean-Jacques BOFFA, Pr · +33 1 56 01 60 29 · jean-jacques.boffa@aphp.fr
Always discuss trial participation with your own doctor first.
| Service de Néphrologie et Dialyses, Hôpital Tenon | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06820866